Contact
Please use this form to send email to PR contact of this press release:
YMAB NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – YMAB
TO: